When comparing various antiretroviral and induction combinations in 77 HIV infected kidney transplant recipients, the use of rabbit anti-thymocyte globulin for induction and protease inhibitor sparing antiretrovirals resulted in a trend toward lower rejection and improved graft survival. Abstract Purpose Kidney transplantation has a survival...

Abstract Background Solid organ transplant recipients are at an increased risk for anogenital Human Papillomavirus (HPV)-related disease, including anal high-grade squamous intraepithelial lesions (HSIL) and anal squamous cell cancer (ASCC). Guidelines for ASCC screening in transplant recipients are limited. Our aim was to understand current...

Abstract Over the last decade, the therapeutic landscape for hematological malignancies (HMs) has witnessed a remarkable surge in the development of novel biological and small-molecule-targeted immunomodulatory agents. These therapies have drastically improved survival, but some come at the cost of increased risk of bacterial, viral, and/or fungal...

Transplant Infectious Disease, EarlyView.

Abstract This case involves a 53-year-old female with concurrent acute myeloid leukemia (AML) and multiple myeloma. She underwent cytarabine and daunorubicin (7+3) induction chemotherapy followed by cytarabine (HiDAC) consolidation, with an early AML relapse requiring azacitidine and venetoclax therapy. She achieved complete remission and incomplete...

Transplant Infectious Disease, EarlyView.